Inflammation and Carcinogenesis of the Biliary Tract: Update On Endoscopic Treatment

Clinical Gastroenterology and Hepatology

Volumn 7, Issue 11 SUPPL., 2009, Pages

  Kozarek, Richard A ^a  

^a VIRGINIA MASON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; BILE DUCT CARCINOMA; BILIARY TRACT INFLAMMATION; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CARCINOGENESIS; COMPUTER ASSISTED TOMOGRAPHY; ENDOSCOPIC SURGERY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PALLIATIVE THERAPY; PERCUTANEOUS TRANSHEPATIC DRAINAGE; STENT;

BILIARY TRACT NEOPLASMS; CHOLANGITIS; DRAINAGE; ENDOSCOPY, DIGESTIVE SYSTEM; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STENTS;

EID: 71849104080     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2009.08.026     Document Type: Article

References (67)

1. Van Beers B.E. Diagnosis of cholangiocarcinoma. HPB (Oxford) 10 (2008) 87-93
2. Charatcharoenwitthaya P., Enders F.B., Halling K.C., et al. Utility of serum markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis. Hepatology 48 (2008) 1106-1117
3. Athanassiadou P., and Grapsa D. Value of endoscopic retrograde cholangiopancreatography-guided brushings in preoperative assessment of pancreaticobiliary strictures: what's new?. Acta Cytol 52 (2008) 24-34
4. Nguyen K., and Sing Jr. J.T. Review of endoscopic techniques in the diagnosis and management of cholangiocarcinoma. World J Gastroenterol 14 (2008) 2995-2999
5. Small A.J., and Baron T.H. Novel endoscopic approaches for assessing biliary tract diseases. Curr Opin Gastroenterol 24 (2008) 357-362
6. Parsi M.A., Li A., Li C.P., et al. DNA methylation alterations in endoscopic retrograde cholangiopancreatography brush samples of patients with suspected pancreaticobiliary disease. Clin Gastroenterol Hepatol 6 (2008) 1270-1278
7. Weber A., von Weyhern C., Fend F., et al. Endoscopic transpapillary brush cytology and forceps biopsy in patients with hilar cholangiocarcinoma. World J Gastroenterol 14 (2008) 1097-1101
8. Blechacz B., and Gores G.J. Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology 48 (2008) 308-321
9. Ustundag Y., and Bayraktar Y. Cholangiocarcinoma: A compact review of the literature. World J Gastroenterol 14 (2008) 6458-6466
10. Yachimski P., and Pratt D.S. Cholangiocarcinoma: natural history, treatment, and strategies for surveillance in high-risk patients. J Clin Gastroenterol 42 (2008) 178-1790
11. Sainani N.I., Catalano O.A., Holalkere N.S., et al. Cholangiocarcinoma: current and novel imaging techniques. Radiographics 28 (2008) 1263-1287
12. Briggs C.D., Neal C.P., Mann C.D., et al. Prognostic molecular markers in cholangiocarcinoma: a systematic review. Eur J Cancer 45 (2009) 33-47
13. Choi J.Y., Kim M.J., Lee J.M., et al. Hilar cholangiocarcinoma: role of preoperative imaging with sonography, MDCT, MRI, and direct cholangiography. AJR Am J Roentgenol 191 (2008) 1448-1457
14. Inui K., Miyoshi H., and Yoshino J. Bile duct cancers: what can EUS offer?. Intraductal US, 3D-IDUS? FNA-is it possible?. Endoscopy 38 Suppl 1 (2006) S47-S49
15. Moparty B., and Bhutani M.S. Endoscopic ultrasonography for choledocholithiasis and biliary malignancy. Curr Treat Options Gastroenterol 8 (2005) 135-142
16. DeHaan R.D., Kipp B.R., Smyrk T.C., et al. An assessment of chromosomal alterations detected by fluorescence in situ hybridization and p16 expression in sporadic and primary sclerosing cholangitis-associated cholangiocarcinomas. Hum Pathol 38 (2007) 491-499
17. Levy M.J., Baron T.H., Clayton A.C., et al. Prospective evaluation of advanced molecular markers and imaging techniques in patients with indeterminate bile duct strictures. Am J Gastroenterol 103 (2008) 1263-1273
18. Gleeson F.C., Rajan E., Levy M.J., et al. EUS-guided FNA of regional lymph nodes in patients with unresectable hilar cholangiocarcinoma. Gastrointest Endosc 67 (2008) 438-443
19. Kim J.Y., Kim M.H., Lee T.Y., et al. Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: a prospective study compared with conventional imaging. Am J Gastroenterol 103 (2008) 1145-1151
20. Tischendorf J.J.W., Meier P.N., Schneider A., et al. Transpapillary intraductal ultrasound in the evaluation of dominant bile duct stenosis in patients with primary sclerosing cholangitis. Scan J Gastroenterol 42 (2007) 1011-1017
21. Inui K., and Miyoshi H. Cholangiocarcinoma and intraductal sonography. Gastrointest Endosc Clin N Am 15 (2005) 143-155
22. Fritcher E.G., Kipp B.R., Halling K.C., et al. A multivariable model using advanced cytologic methods for the evaluation of indeterminate pancreatobiliary strictures. Gastroenterology 136 (2009) 2180-2186
23. Chen Y.K., and Pleskow D.K. SpyGlass single-operator peroral cholangiopancreatoscopy system for the diagnosis and therapy of bile-duct disorders: a clinical feasibility study (with video). Gastrointest Endosc 65 (2007) 832-841
24. Awadallah N.S., Chen Y.K., Piraka C., et al. Is there a role for cholangioscopy in patients with primary sclerosing cholangitis?. Am J Gastroenterol 101 (2006) 284-291
25. Hoffman A., Kiesslich R., Bittinger F., et al. Methylene blue-aided cholangioscopy in patients with biliary strictures: feasibility and outcome analysis. Endoscopy 40 (2008) 563-571
26. Nimura Y. Staging cholangiocarcinoma by cholangioscopy. HPB (Oxford) 10 (2008) 113-115
27. Meining A., Frimberger E., Becker V., et al. Detection of cholangiocarcinoma in vivo using miniprobe-based confocal fluorescence microscopy. Clin Gastroenterol Hepatol 6 (2008) 1057-1060
28. Larghi A., Lecca P.G., Ardito F., et al. Evaluation of hilar biliary strictures by using a newly developed forward-viewing therapeutic echoendoscope: preliminary results of an ongoing experience. Gastrointest Endosc 69 (2009) 356-360
29. Sano T., Shimada K., Sakamoto Y., et al. One hundred two consecutive hepatobiliary resections for perihilar cholangiocarcinoma with zero mortality. Ann Surg 244 (2006) 240-247
30. Connor S., Barron E., Redhead D.N., et al. Palliation for suspected unresectable hilar cholangiocarcinoma. Eur J Surg Oncol 33 (2007) 341-345
31. Shaib Y.H., Davila J.A., Henderson L., et al. Endoscopic and surgical therapy for intrahepatic cholangiocarcinoma in the United States: a population-based study. J Clin Gastroenterol 41 (2007) 911-917
32. Meyer C.G., Penn I., and James L. Liver transplantation for cholangiocarcinoma: results in 207 patients. Transplantation 69 (2000) 1633-1637
33. Rea D.J., Heimbach J.K., and Rosen C.B. Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg 242 (2005) 451-458
34. Gores G.J., Nagorney D.M., and Rosen C.B. Cholangiocarcinoma: is transplantation an option?. For whom?. J Hepatol 47 (2007) 455-459
35. Soderlund C., and Linder S. Covered metal versus plastic stents for malignant common bile duct stenosis: a prospective, randomized, controlled trial. Gastrointest Endosc 63 (2006) 986-995
36. Lee J.H., Kang D.H., Kim J.Y., et al. Endoscopic bilateral metal stent placement for advanced hilar cholangiocarcinoma: a pilot study of a newly designed Y stent. Gastrointest Endosc 66 (2007) 364-369
37. Stern N., and Sturgess R. Endoscopic therapy in the management of malignant biliary obstruction. Eur J Surg Oncol 34 (2008) 313-317
38. Raju G.S., Sud R., Elfert A.A., et al. Biliary drainage by using stents without a central lumen: a pilot study. Gastrointest Endosc 63 (2006) 317-320
39. Demols A., Maréchal R., Devière J., et al. The multidisciplinary management of gastrointestinal cancer. Biliary tract cancers: from pathogenesis to endoscopic treatment. Best Pract Res Clin Gastroenterol 21 (2007) 1015-1029
40. Válek V., Kysela P., Kala Z., et al. Brachytherapy and percutaneous stenting in the treatment of cholangiocarcinoma: a prospective randomised study. Eur J Radiol 62 (2007) 175-179
41. Shinohara E.T., Mitra N., Guo M., et al. Radiation therapy is associated with improved survival in the adjuvant and definitive treatment of intrahepatic cholangiocarcinoma. Int J Radiat Oncol Biol Phys 72 (2008) 1495-1501
42. Stein D.E., Heron D.E., Rosato E.L., et al. Positive microscopic margins alter outcomes in lymph node-negative cholangiocarcinoma when resection is combined with adjuvant radiotherapy. Am J Clin Oncol 28 (2005) 21-23
43. Deviere J., Baize M., de Toeuf J., et al. Long-term follow-up of patients with hilar malignant stricture treated by endoscopic internal biliary drainage. Gastrointest Endosc 34 (1988) 95-101
44. De Palma G.D., Galloro G., Siciliano S., et al. Unilateral versus bilateral endoscopic hepatic duct drainage in patients with malignant hilar biliary obstruction: results of a prospective, randomized, and controlled study. Gastrointest Endosc 53 (2001) 547-553
45. Freeman M.L., and Overby C. Selective MRCP and CT-targeted drainage of malignant hilar biliary obstruction with self-expanding metallic stents. Gastrointest Endosc 58 (2003) 41-49
46. Ramchandani M., Lakhtakia S., Gupta R., et al. A new biliary "Y" stent for hilar tumors. Endoscopy 39 Suppl 1 (2007) E47-E48
47. Prasad G.A., Wang K.K., Baron T.H., et al. Factors associated with increased survival after photodynamic therapy for cholangiocarcinoma. Clin Gastroenterol Hepatol 5 (2007) 743-748
48. Kahaleh M., Mishra R., Shami V.M., et al. Unresectable cholangiocarcinoma: comparison of survival in biliary stenting alone versus stenting with photodynamic therapy. Clin Gastroenterol Hepatol 6 (2008) 290-297
49. Rumalla A., Baron T.H., Wang K.K., et al. Endoscopic application of photodynamic therapy for cholangiocarcinoma. Gastrointest Endosc 53 (2001) 500-504
50. Berr F., Wiedmann M., Tannapfel A., et al. Photodynamic therapy for advanced bile duct cancer: evidence for improved palliation and extended survival. Hepatology 31 (2000) 291-298
51. Ortner M.E.J., Caca K., Berr F., et al. Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study. Gastroenterology 125 (2003) 1355-1363
52. Witzigmann H., Berr F., Rinkel U., et al. Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection. Ann Surg 244 (2006) 230-239
53. Dumoulin F., Gerhardt T., Fuchs S., et al. Phase II study of photodynamic therapy and metal stent as palliative treatment for nonresectable hilar cholangiocarcinoma. Gastrointest Endosc 57 (2003) 860-867
54. Wang J.B., and Liu L.X. Use of photodynamic therapy in malignant lesions of stomach, bile duct, pancreas, colon and rectum. Hepato-gastroenterology 59 (2009) 718-724
55. Ortner M.A., Liebetruth J., Schreiber S., et al. Photodynamic therapy of nonresectable cholangiocarcinoma. Gastroenterology 114 (1998) 536-542
56. Harewood G.C., Baron T.H., Rumalla A., et al. Pilot study to assess patient outcomes following endoscopic application of photodynamic therapy for advanced cholangiocarcinoma. J Gastroenterol Hepatol 20 (2005) 415-420
57. Shim C.S., Cheon Y.K., Cha S.W., et al. Prospective study of the effectiveness of percutaneous transhepatic photodynamic therapy for advanced bile duct cancer and the role of intraductal ultrasonography in response assessment. Endoscopy 37 (2005) 425-433
58. Rauws E.A. Photodynamic therapy and Klatskin tumour: an overview. Scand J Gastroenterol Suppl 243 (2006) 135-138
59. Spinelli P., Mancini A., and Dal Fante M. Endoscopic treatment of gastrointestinal tumors: indications and results of laser photocoagulation and photodynamic therapy. Semin Surg Oncol 11 (1995) 307-318
60. Saluja S.S., Gulati M., Garg P.K., et al. Endoscopic or percutaneous biliary drainage for gallbladder cancer: a randomized trial and quality of life assessment. Clin Gastroenterol Hepatol 6 (2008) 944-950
61. Paik W.H., Park Y.S., Hwang J.H., et al. Palliative treatment with self-expandable metallic stents in patients with advanced type III or IV hilar cholangiocarcinoma: a percutaneous versus endoscopic approach. Gastrointest Endosc 69 (2009) 55-62
62. Prat F., Lafon C., De Lima D.M., et al. Endoscopic treatment of cholangiocarcinoma and carcinoma of the duodenal papilla by intraductal high-intensity US: results of a pilot study. Gastrointest Endosc 56 (2002) 909-915
63. Prat F., Lafon C., Theillière J.Y., et al. Destruction of a bile duct carcinoma by intraductal high intensity ultrasound during ERCP. Gastrointest Endosc 53 (2001) 979-800
64. Itoi T., Yamanouchi E., Ikeda T., et al. Magnetic compression anastomosis: a novel technique for canalization of severe hilar bile duct strictures. Endoscopy 37 (2005) 1248-1251
65. Lewis J.T., Talwalkar J.A., Rosen C.B., et al. Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence. Am J Surg Pathol 31 (2007) 907-913
66. Hughes N.R., Pairojkul C., Royce S.G., et al. Liver fluke-associated and sporadic cholangiocarcinoma: an immunohistochemical study of bile duct, peribiliary gland and tumour cell phenotypes. J Clin Pathol 59 (2006) 1073-1078
67. Ben-Menachem T. Risk factors for cholangiocarcinoma. Eur J Gastroenterol Hepatol 198 (2007) 623-630